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Abstract 
Background: 
Group B beta-hemolytic streptococcal (GBS) disease causes significant 
neonatal morbidity and mortality in the United States. Universal screening and 
use of intrapartum prophylaxis for women identified to be at risk has been 
promoted through recent Centers for Disease Control (CDC) national guidelines. 
Despite the recommendation for universal screening, many women present in 
labor with unknown GBS status. Interventions that decrease rates of unknown 
GBS status may improve providers' ability to effectively implement the GBS 
prevention guideline. 
Research Question: r 
Does electronic access to GBS screening results reduce the rates of both 
unknown GBS status and subsequent delivery of inappropriate care for the 
prevention of GBS disease? 
Study Design: 
A retrospective cohort study using data from an extensive perinatal 
database is described. Included subjects are women delivering babies at 
University of North Carolina (UNC) Women's Hospital between 1996 and 2003, 
2 
who received care at a university managed or affiliated prenatal care site. Rates 
of delivery of appropriate care based on GBS status are assessed and the effect of 
access to an electronic medical record on rates of inappropriate care is examined. 
Results: 
A total of 7102 births were eligible for assessment of adherence to GBS 
prevention guidelines. 28.3% of women had unknown GBS status and 24.8% of 
the entire sample received inappropriate care. Lack of an electronic medical 
record (EMR) was significantly associated with both a higher rates of both 
unknown GBS status (OR 1.54. 95%CI 1.34-1.71) and inappropriate care (OR 
1.12, 95% CI 1.11-1.13). 
Conclusions: 
Results of prenatal GBS screening, required in order to correctly 
implement GBS preventive measures, are often missing on admission to the 
hospital for delivery. Access to an electronic medical record improves the ability 
of providers to maximize the protective effect of GBS prevention measures. 
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Background: 
Group B Streptococcal disease (GBS) 
Group B beta streptococcal (GBS) disease is the leading cause of 
preventable neonatal sepsis in developed countries, causing approximately 1600 
illnesses and 80 deaths annually.[l] In 2002, the nationally projected rate of early-
onset disease was 0.4/1,000 persons< 1 year of age.[2] Though the number of 
surviving infants is increasing, devastating neurologic damage often results in 
lifelong care needs.[3, 4] Ten to thirty percent of the population of child-bearing 
women are colonized with GBS in either the gastrointestinal or genitourinary 
tract.[5] Exposure to GBS occurs during labor as the neonate passes through the 
birth canal.[6] Early onset GBS disease typically manifests in the first 24-48 
hours of life, presenting as pneumonia and, less frequently, as meningitis.[!] 
GBS prevention guidelines 
In 1996, based on evidence that the use of prophylactic antibiotics in at 
risk women during labor reduces the number of affected newborns, the Centers 
for Disease Control (CDC) published a national guideline for the prevention of 
GBS disease. This initial guideline promoted the identification of at risk women 
by either screening in the third trimester or assessment of risk factors during 
labor. In 2002, a prospective study comparing the two identification methods 
demonstrated greater reduction of affected neonates with universal screening.[?] 
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The CDC subsequently revised the guideline in 2002 to recommend that prenatal 
care providers screen all pregnant women at 35-37 weeks of pregnancy and 
administer prophylactic antibiotics during labor to all women with evidence of 
GBS colonization.[S] 
Implementation of guidelines 
Guidelines such as these published by the CDC are playing an 
increasingly important role in attempts to improve the quality of health care 
delivery in the U.S. ([9]) Implementation of guidelines is challenging, however, 
in the context of complex and varied care delivery systems. Research has 
identified a number of barriers to full implementation of guidelines. These 
include lack of provider knowledge or acceptance, lack of data required to follow 
the recommended algorithms, lack of access to diagnostic or treatment modalities, 
and inaccessibility. [10, 11). In the absence of full adherence to 
recommendations, clinical practice often falls short of reaching desired goals; the 
case of GBS prevention provides a striking example. 
Full implementation of the GBS prevention guideline involves the 
completion and integration of several distinct tasks. First, women receiving 
prenatal care must be screened between 35-37 weeks gestation. The results of this 
testing must be readily available when they present to labor and delivery. Finally, 
using outpatient GBS culture data, the inpatient provider must correctly institute 
therapy for women at risk. Rigorous assessment of adherence to this guideline, 
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then, requires evaluation of the degree to which each of these components is 
accomplished. 
Assessment of GBS prevention guideline 
The ultimate outcome of interest, rate of affected neonates, has been 
closely followed in the wake of the CDC guidelines, largely through the Active 
Bacterial Core Surveillance (ABCs) program.[1) Rates of intrapartum antibiotic 
prophylaxis to GBS +women, [12-15) rates of anaphylaxis and other maternal 
medical outcomes, [16-19]and effect of the new guidelines on length of hospital 
stay and rate of laboratory testing for neonates[?, 17, 20-24) have all been 
assessed. In addition, the CDC has followed the rates of adoption of the 
guidelines at both the provider and hospitallevel.[25) [26) 
Fewer studies have rigorously assessed the specific processes associated 
with adherence to the guideline; the available data suggests that several 
components of the guideline leave room for substantial improvement in the 
delivery of care. [27, 28] Most notably, a 2003 multi-state study showed that, 
while 89% of GBS positive women received intrapartum antibiotic prophylaxis 
(lAP), screening results were documented in only 52% of pregnancies across an 
eight state surveillance area. This raises concern for a high rate (48%) of women 
whose GBS status remained unknown at the onset of labor. [29] 
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Potential of electronic medical record system to improve care 
The methods by which GBS culture results are made available in the 
inpatient setting and rates of availability of this data have not been assessed, 
despite their importance in allowing for full guideline implementation. Clinical 
care of pregnant women is often shared between distinct prenatal and delivery 
care providers. Given the unpredictable timing of onset of labor, and fact that 
much of labor care is delivered during after hours, the systems in place for 
transferring updated prenatal information are often complex and time-intensive. 
Common strategies include repeated photocopying and faxing of prenatal records 
at weekly intervals during the last month of pregnancy. Under these 
circumstances, the potential for missing or lost data is significant, with 
implications for both overuse and underuse of lAP. 
Shared Care 
In shared clinical care systems, the electronic medical record (EMR) holds 
promise to improve outcomes by making data available across providers and 
geographic sites. Branger and colleagues implemented an electronic medical 
record among primary and specialty clinicians sharing the care of diabetic patients 
and demonstrated increased availability of data and slightly improved clinical 
outcomes.[30] More recently, electronic access to clinical data was studied in an 
emergency department (ED) setting. Researchers found a reduction in cost and 
improved physician satisfaction associated with enhanced access to clinical 
data.[31] 
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In the case of a patient admitted in labor, the presence of an electronic 
medical record system linking outpatient records with inpatient clinical care 
allows immediate access to accurate GBS results, thus reducing the likelihood of 
error in adhering to guidelines for GBS prevention. This study will test whether 
EMR access to GBS results is associated with a decreased number of women with 
an unknown GBS status at entry to labor and delivery and will look at the 
relationship between EMR access and rates of appropriate care. Implications 
regarding quality of care will be discussed. 
(Addendum A: EMR and Improved Clinical Outcomes in Shared Care Settings: 
Review of the Literature) 
Research Setting 
The University of North Carolina Women's Hospital provides primary, 
secondary and tertiary obstetric services to pregnant women in eastern and central 
North Carolina. This large system comprises a number of outpatient prenatal care 
sites managed by the Departments of Obstetrics and Gynecology (OBGYN) or 
Family Medicine (FM). In addition, a number of independent sites providing 
prenatal care services are affiliated with UNC Hospitals (UNCH). These sites 
contract with the above departments for obstetric services for their patients and, as 
such, are subject to UNCH policies and procedures relating to pregnancy care. In 
all, 7 prenatal care sites are managed by the FM department, 16 by the OBGYN 
department, and 1 site has care delivered by both departments. The hospital 
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averaged approximately 2,600 deliveries/year between May 1996 and September 
2003. 
UNC Electronic Medical Record History 
All outpatient sites providing prenatal care for patients delivering at UNC 
Women's Hospital use a paper medical record for prenatal care. Beginning in 
1991, the University of North Carolina Hospitals adopted an electronic medical 
record known as the Clinical Information System (CIS). This system was used on 
Labor and Delivery from its inception. A subsequent transition to a web-based 
medical record system (WebCIS) occurred in April 2002. Results of laboratory 
tests performed at the UNC McLendon Laboratory have been available to 
clinicians via the electronic medical record since 1991 with the original CIS 
system. Through these systems, providers on the labor and delivery unit have had 
electronic access to any clinical data generated by the McLendon Laboratory 
since 1991.[32] 
History of UNC GBS Prevention Policies 
Three written policies for GBS prevention were identified from 1994-
present. Since 1994, UNC has promoted a policy of universal screening of 
women for GBS colonization. Women have been identified as candidates for 
intrapartum antibiotic prophylaxis (IAP) if culture positive on screening between 
33-37 weeks, if a urine culture was positive for GBS or if they had a positive 
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history of a previously affected newborn. All policies have advocated empiric 
treatment of women with unknown GBS status.[15, 33-35] 
Suggested regimens for lAP at UNCH have shifted in accordance with 
changes in the CDC guidelines between 1996 and 2002. The 1998 UNCH report 
recommends penicillin G and ampicillin for lAP, and suggests clindamycin, or 
erythromycin for penicillin-allergic patients. The revised 2001 UNCH policy 
includes the above except erythromycin, and adds cefazolin for patients with mild 
penicillin allergies. In addition, vancomycin is listed for use in the setting of 
identified resistance to clindamycin for penicillin-allergic patients. 
Methods 
We developed a retrospective cohort study using the University of North 
Carolina (UNC) Department of OBGYN perinatal database. Since 1996, one to 
two full time employees have abstracted data from perinatal charts and 
maintained the database. They review all available antepartum and intrapartum 
records of women delivering at UNC Women's Hospital within approximately 
one week of discharge. Abstraction forms and protocols have been in place and 
unchanged since the inception of this database. Data has been primarily used to 
generate comprehensive clischarge summaries for distribution back to referring 
physicians. [36, 37] 
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Study participants 
The population studied included all women receiving care at prenatal care 
(PNC) sites either operated by or affiliated with UNC Hospitals who delivered at 
UNCH from Aprill996 through September 2003. These PNC sites are all 
subject to UNCH policies and procedures regarding GBS prevention. Women 
referred from outside sites were excluded. Women were also excluded if they 
delivered at a gestational age of <37 weeks as they may not yet have been 
screened. Women delivered by elective or otherwise planned cesarean section 
were excluded as the CDC guideline for intrapartum antibiotic prophylaxis (lAP) 
use applies only to women who experience labor. Finally, women with an 
intrauterine fetal demise (IUFD) or terminating pregnancy for anomalies were 
also excluded, as were women whose deliveries occurred prior to admission. I 
These exclusion criteria were applied to limit participants to women who were 
candidates to receive full implementation of the guidelines for GBS prevention. 
For purposes of more clearly determining use of lAP intended for the 
prevention of GBS, a decision rule was developed to select a population of 
women whose antibiotic regimen likely represented lAP for GBS. Accordingly, 
women who received more than one antibiotic during labor were excluded. From 
the remaining women, those whose single antibiotic during labor was not one 
indicated for lAP according to the UNCH GBS or CDC prevention policies were 
excluded. 
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Demographic and Clinical Characteristic 
The following demographic information was obtained: age, race, marital 
status, type of prenatal care site, and specialty management of prenatal care site 
(OBGYN or FM). Clinical data included parity (dichotomized into primiparous, 
multiparous), estimated gestational age at delivery (in weeks), APGAR scores at 1 
and 5 minutes, neonatal death, type of delivery (vaginal, cesarean) and 
birthweight. Results of GBS screening were coded as positive or negative and 
cases with missing values were coded as unknown. Use of an antibiotic during 
labor was treated as a categorical variable (none, a specific lAP antibiotic) and 
subsequently dichotomized into GBS intrapartum antibiotic prophylaxis 
administered or not. 
Independent variables 
Access to lab result via electronic record was used as the primary 
independent variable. For each prenatal care site, laboratory services have been 
provided by either UNC McLendon Laboratory or by an independent commercial 
laboratory.[38] McLendon laboratory results have been automatically available in 
the UNC electronic medical record since 1991.[39] For each birth, based on 
prenatal care site, access to laboratory results via the electronic record was 
dichotomized. 
Outcome measures 
A dichotomous outcome describing use and nonuse of lAP during labor as 
appropriate or inappropriate was applied using decision rules from the UNC 
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School of Medicine GBS prevention guideline (approved 5/30/01, revised 10/02). 
Intrapartum antibiotic prophylaxis was defined as use of a single lAP antibiotic 
during labor. Appropriate care included use of lAP for women who had a GBS 
positive screen, met criteria for automatic prophylaxis or had unknown GBS 
status. Appropriate care also included withholding lAP for women with negative 
GBS screening tests. Women for whom these conditions were met were 
combined into the appropriate care category. 
Inappropriate care included non-use of lAP for women who had a GBS 
positive screen, met criteria for automatic prophylaxis, or had unknown GBS 
status. Use of lAP in women with negative GBS screening tests was also 
considered inappropriate care. 
Statistical analysis 
Descriptive statistics were used to characterize the study sample. 
Categorical variables were compared using the chi-square statistic. T -tests were 
used to test for differences in the means for continuous variables. Odds ratios 
were calculated to assess the strength of significant associations. For all statistical 
tests, significance was set at 0.05 using two-tailed tests. All analyses were 
performed using SPSS statistical software. (SPSS 11.5 for Windows) 
Study Approval 
The UNC SOM institutional review board approved this study and a 
lllP AA waiver of informed consent was granted. 
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Results: 
Study Population 
Data were available for 18,652 births. Application of all exclusion criteria 
reduced eligible births to 8,426. (Figure 1) Of these, a further 1,324 were 
excluded for missing drug data or multiple antibiotic administration, leaving 
7,102 cases for the final analysis. (Figure 2) 
The mean age of the sample was 26 years. Women in the sample were 
white (40.1 %), Hispanic (35.3% ), or black (20.5%) with 4.2% identified as 
other/unspecified for racial or ethnic group. Just under half of the women in the 
sample were married and 43.7% were primiparous. Vaginal delivery was I documented for 90% of the sample. Most of the prenatal care was provided in 
the UNC OB sites, community health centers, or local health departments. Mean 
birthweight for this sample of women with term deliveries was 3407 grams. 
Electronic laboratory record access was available to providers of 48.4% (n= 3436) 
of women in the sample. (Table 1) 
Rates ofGBS status and inappropriate care 
In the study sample, 19.4% of women were GBS positive, 52.3% GBS 
negative and 28.3% of the sample had unknown GBS results. Approximately one 
third of the sample received lAP. Overall, one quarter of the sample received 
inappropriate care (n=1761). The rate of inappropriate care was highest among 
women with unknown GBS status (60.1 %). Known GBS positive and GBS 
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negative women had low rates of inappropriate care (8.7% and 8.1 %, 
respectively). (Figure 2) 
Factors associated with rates ofGBS status and inappropriate care 
Lack of electronic laboratory record access was associated with an 
increased rate of inappropriate care (OR=l.12, 95% CI 1.11-1.13). Bivariate 
analysis demonstrated a significantly increased risk for unknown GBS status in 
the setting of no EMR access (OR= 1.54, 95%CI 1.34-1.71). Relative to women 
with known positive GBS results, OR for inappropriate care in women with 
unknown GBS status was 8.70 (95% CI 7.14-10.00). 
Discussion: 
Rate of unknown GBS status 
One quarter of women eligible for GBS prophylaxis at this single, large 
academic institution between 1996 and 2003 received inappropriate care relative 
to the current institutional guideline for the prevention of GBS disease. Twenty-
eight percent of this sample had an unknown GBS status. This rate is expected to 
underestimate the actual rate of unknown status in the general population of 
women presenting to UNCH in labor. Since data is abstracted several days after 
admission, allowing time for chart retrieval, greater availability of results than 
observed at the time of admission is anticipated. Rates of unknown status as high 
as 48% in unselected populations have been reported previously.[29] The high 
rate of unknown GBS status demonstrated in this population clearly poses an 
important barrier to full implementation of GBS prevention guidelines. 
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Explanations for an unknown GBS status on admission to labor and 
delivery include lack of screening and lack of available results to the inpatient 
provider. The data did not allow for a direct assessment of these subsets. In this 
population of women at gestational age >37 weeks, the likelihood of prenatal 
screening is optimized. We believe that poor availability of GBS screening results 
on labor and delivery explains the high rate of unknown GBS status. 
In practice, labor and delivery providers' access to patients' GBS results is 
limited under two circumstances. First, prenatal care providers may not clearly 
and accurately document the result in the prenatal chart. Second, hospital 
providers may not have access to a copy of the prenatal chart. For patients with 
laboratory data directly entered into an EMR, a backup system exists to overcome 
both of these obstacles. The fact that EMR access was associated with a lower 
rate of unknown status supports our clinical experience that unknown GBS status 
results primarily from limitations in data availability rather than from lack of 
screening. 
Rate of inappropriate care 
Unknown GBS status was strongly associated with receipt of 
inappropriate care. Compared to women with positive GBS cultures, women with 
an unknown GBS result were eight times as likely to receive inappropriate care, 
defined as lack of lAP under UNCH policy. Rates of inappropriate care were 
much lower among women with either positive or negative results. 
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The 1996 CDC guideline and subsequent 2002 revision promote treatment 
of women with unknown GBS status based on an assessment of risk factors at the 
time of labor. Risk factors include maternal temperature greater than or equal to 
100.4, rupture of membranes greater than 18 hours, and fetal prematurity. The 
presence of risk factors was not analyzed for this project since UNCH GBS 
prevention policies have promoted a more conservative approach, recommending 
empiric treatment of all GBS unknown women. 
Effect of EMR access on delivery of care 
Our hypothesis, that access to GBS results in an EMR would decrease the 
rate of women receiving inappropriate care was supported in this analysis. The 
strong relationship between EMR access and lower rates of unknown GBS status I 
suggests a primary mechanism through which EMR access affects the rate of 
inappropriate care. Information on specific systems of prenatal record data 
transfer from the included PNC sites to the hospital was not available for this 
project. It is possible that site-specific systems play a similarly large role in 
determining the rate of women with unknown GBS status. 
Strengths 
The high quality of the data analyzed in answering the research question 
lends great strength to this study. The data is felt to be truly representative of the 
population and services provided for several reasons. At this institution, data 
have been collected by a total of 5 trained full time employed abstractors over the 
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6-year study period, using a standarclized protocol.[40] Data collection occurs at 
the point of service on an ongoing basis, decreasing chances for error or missing 
data. The large number of cases increases the power to detect clifferences. The 
use of data from a single institution decreases error due to heterogeneous clinical 
protocols and practices for GBS prevention. Last, the nature of the fixed 
relationships between practices and laboratory services is such that the presence 
or absence of access to electronic laboratory results is clear. 
In addition, the number of conservative assumptions made in case 
selection and subsequent analysis strengthens results. The likelihood for bias has 
been greatly reduced by eliminating cases not eligible for full implementation of 
screening and treatment according to the guideline. 
Considerations 
GBS status 
In the process of data abstraction, GBS status was not derived clirectly 
from or checked against actual laboratory results. Instead, GBS status was 
determined from either the prenatal record laboratory results section, or from 
inpatient admission notes in which GBS status is almost universally noted.[36] In 
cases where the prenatal record had no documented GBS result but laboratory 
results are electronically available, (prenatal care source is affiliated with the 
UNC McLendon Laboratory), providers are able to access the result and 
document the woman's GBS status in the admission note. As such, GBS results 
for women with electronic access reflect both accurately documented, available 
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results of screening as well as undocumented, but electronically available results. 
This specific aspect of data collection allows for an accurate assessment of the 
effect of EMR access on rate of unknown GBS status. 
One further note relating to GBS status is that the coding for this variable 
does not allow a separate category for women meeting predefined criteria for lAP 
prophylaxis (GBS bacteruria, previous GBS-affected neonate). Women meeting 
these criteria automatically receive lAP and do not require GBS cultures in the 
third trimester. When documentation in the prenatal and inpatient records for 
these women clearly indicates the anticipated need for GBS prophylaxis, even in 
the absence of GBS cultures, they are classified as GBS positive in the 
dataset.(36] Since these women are ultimately classified as either positive or 
unknown, with the same recommendation of lAP, final analysis of appropriate 
care is unaffected. 
Bias may have been introduced in the delineation of medication regimens 
consistent with intrapartum antibiotic prophylaxis. Medication administration is 
well documented in the database but indications for medical therapy are left to 
interpretation. Both the CDC and UNCH guidelines have advocated only single 
antibiotic regimens for the prophylaxis of GBS disease. As such, women 
receiving multiple antibiotics during labor were excluded. 
The potential exists for missed cases of appropriately treated women in the 
setting of both GBS risk and a concurrent infectious process requiring treatment. 
Any such bias would serve to diminish our ability to detect a difference between 
those receiving appropriate and inappropriate care. Given the absence of any 
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intrapartum infectious process routinely treated with a single agent, and the fact 
that differential misclassification of these women based on EMR access is 
unlikely, the risk of serious confounding is low. 
Last, further analysis of any significant differences between patients with 
EMR access and those without would allow an understanding of any additional 
factors that could confound our results. 
Conclusion 
This study adds to our understanding of the need to assess processes 
associated with the implementation of guidelines. One goal of any GBS 
prevention effort is to minimize the number of women with unknown GBS status 
at the time of labor in order to maximize benefit and limit risk for both women 
and their newborns. Maternity care systems characterized by high rates of 
unknown GBS status face important challenges to both the quality and cost of 
care. 
We have identified a high rate of unknown GBS status at a large academic 
center with multiple external sites referring patients for delivery. Future efforts 
to track rates of unknown status in a variety of settings and to better understand 
systems that support the availability of accurate GBS results in the hospital are 
essential. Rates of GBS unknown status were reduced in the setting of access to 
an EMR. EMR access was also associated with lower rates of inappropriate care. 
Expansion of EMR availability to surrounding outpatient sites is currently being 
considered at UNCH. Prospective assessment of outcomes such as those 
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examined in this study at individual PNC sites before and after instituting EMR 
access is recommended to further our understanding of the effect of this 
intervention. 
A growing body of research seeks to demonstrate clinical benefit 
associated with technologies such as electronically available clinical data. Shared 
care settings in which multiple providers require access to the same clinical data 
are uniquely suited to demonstrate the potential benefit of EMR access. Rigorous 
assessment of such technologies faces substantial challenges given the 
tremendous resources involved in developing such systems, and the difficulty in 
creating settings for randomized, controlled trials.[41] Settings such as that 
described for this study may provide practical opportunities to better understand 
the impact of EMRs. Future prospective study should consider the even greater 
potential effect of computerized decision support in which electronic clinical data 
is linked in real time with recommendations for care from accepted guidelines. 
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Table 1. Demographics 
Appropriate Care 
N= 5341 (75.2%) 
Age (years) 26.15 
<20 802 (74.5) 
20-35 4152 (74.5) 
> 35 386 (73.8) 
Race 
White 2110 (74.1) 
Black 1068 (73.5) 
Hispanic* 1931 (76.9) 
Other 232 (78.6) 
Marital Status (%single)'# 2350 (73.7) 
Parity(% primiparous)* 2375 (76.4) 
Type of Delivery 
Total vaginal deliveries 4887 (76.2) 
Total Cesarean section 454 (65.8) 
Specialty of PNC site * 
FM 556 (69.1) 
OB 4785 (75.9) 
Gestational Age at Deli very 39.36 
(mean weeks)** 
Birthweight (grams)* 3419.02 
APGAR! 7.99 
APGAR5 8.84 
Neonatal Death/Stillborn- 6 (75) 
combined (%) 
* Indicates statistically significant at the 0.05 level 
** sample includes GA;:>: 37 weeks 
#N= 7087 
Inappropriate Care 
N=1761 (24.8%) 
26.06 
274 (25.5) 
1350 (25.5) 
137 (26.2) 
735 (25.9) 
386 (26.5) 
577 (23.1) 
63 (21.4) 
838 (26.3) 
730 (23.6) 
1525 (23.8) 
236 (34.2) 
249 (30.9) 
1512 (24.1) 
39.13 
3372.35 
8.03 
8.85 
2 (25) 
Total 
N=720 
1 
1076 
5502 
523 
2845 
1454 
2508 
295 
3188 
3105 
6412 
690 
805 
6297 
8 
25 
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Table 2. GBS status by EMR access 
GBS known(+ or-) 
EMR access 2622 
No EMR access 2482 
OR for unknown GBS (no EMR/EMR) 
1184/814 = 1.54 (CI 1.34-1.71) 
2482/2622 
GBS unknown 
814 
1184 
L 
' I 
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T bl 3 T a e . 1ypeo f C b GBS tat are y s us 
Appropriate Inappropriate Total 
Care Care 
GBS positive 1105 (83.3) 221 (16.7) 1326 
GBS negative 3508 (92.9) 270 (7.1) 3778 
GBS unknown 728 (36.4) 1270 (63.6) 1998 
Total 5341 (75.2) 1761 (24.8) 7102 
Appropriate care for GBS unknown relative to positive: 
OR= 0.115, 95% CI0.10-0.14 
Inappropriate care for GBS unknown relative to positive: 
OR= 8.69, 95% CI 7.14-10.00 
OR for 
appropriate care 
(95% CI) 
1 
2.60 (2.15- 3.14) 
0.12 (0.10-0.14) 
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Table 4. lAP use bv GBS status 
lAP No lAP Total 
GBS positive 1211 (91.3%) 115 (8.7%) 1326 
GBS negative 306 (8.1 %) 3472 (91.9%) 3778 
GBS unknown 797 (39.9%) 1201 (60.1%) 1998 
Total 2314 (32.6%) 4788 (67.4%) 7102 
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T bl 5 T a e . ypeo f b EMR care >y access 
Appropriate Care 
EMR access 2621 
No EMR access 2720 
Total 5341 (75.2%) 
OR for inappropriate care (no EMR!EMR) 
946/2720 X 2621/815 
= 1.12, 95% CI = 1.11-1.13 
Inappropriate Care 
815 
946 
1761 (24.8%) 
I 
i 
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Addendum 
EMR and Improved Clinical Outcomes in Shared Care Settings: Review of 
Literature 
Information technology has been touted as one means by which error in 
the U.S. health care system can be dramatically reduced. The potential for wider 
dissemination and use of evidence-based guidelines and the associated impact on 
clinical outcomes has received increasing attention in recent years with mixed 
results.[42] At the level of individual patient care, improving the accuracy of and 
access to data in the medical record are important goals. Limitations of paper 
medical records have been demonstrated.[43, 44] Electronic medical records 
(EMRs) may enhance patient care by putting more organized, easy to access 
clinical data in the hands of providers. [44, 45] To date, however, evidence of 
actual clinical benefit linked to the use of an EMR is limited. 
The potential added utility of an EMR in directly linking providers sharing 
the care of an individual patient has been explored in several areas of medical 
practice. Given the increasingly fragmented nature of medical care in the U.S., 
this potential for benefit deserves rigorous assessment. A review of the literature 
yielded a limited number of studies attempting to assess the value of an electronic 
record system to patients and providers in the setting of shared medical care. 
Shared Care: Diabetes 
In 1999, Branger, eta! reported results of a non-randomized controlled 
trial conducted in the Netherlands over a one year period assessing the impact 
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of improved communication between general practitioners (GPs) and 
specialists in the care of diabetic patients [30]. The intervention consisted of 
an inter-physician communication feature added to a pre-existing electronic 
medical record system. Control GPs communicated with specialists by the 
traditional paper-based manner. The primary outcome of interest was the 
number of messages exchanged by the providers. In addition, documentation 
of a number of diabetes parameters in the medical record was measured and 
hemoglobin A 1 C levels were compared as a clinical outcome measure. 
Results of this study showed a significant increase in messages 
between providers (in both directions), over the study period. They also 
showed significantly more data in the patient record for 6 of 10 diabetes 
parameters. Comparison of the mean differences in HgbAlC did not yield a 
significant difference between intervention and control groups. Several 
features of the study design limit interpretation of results. Most notably, the 
non-random selection of intervention and control groups introduces bias that 
may lead to an overestimate of effect since intervention GPs were identified 
by higher numbers of referred diabetics and may have provided care 
differently. The authors, however, used an analysis of covariance allowing for 
a distinction to be made between effects due to baseline differences and those 
due to exposure to the intervention. 
The short study period and small number of diabetic patients with 
HgbA1C testing in the pre and post intervention periods (intervention, n=123, 
control n= 32) may have limited the power of this study to demonstrate a 
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difference in mean HbgAlC levels. Despite the lack of benefit in clinical 
outcomes, this study is important in demonstrating improved process 
outcomes as a result of an electronic system for sharing data among providers. 
Shared Care: Emergency Departments 
The emergency room provides an example of another care system in 
which access to important clinical data is often limited. Two papers have 
originated from Wishard Memorial Hospital and Health Services (Wishard) at 
Indiana University using the Regenstrief Medical Record System (RMRS) to 
assess the impact of electronic access to patient data on both processes and 
outcomes of care. The first, in 1982, demonstrated that internists caring for 
patients in an inner-city hospital emergency department (ED) order fewer 
laboratory tests when given a printed summary of clinical data from that 
hospital compared with when they did not receive this summary.[46]. 
Recently, Overhage, et a! completed a randomized controlled trial to r 
more rigorously assess the hypothesis that improving emergency physician's 
access to clinical information from another institution would result in less 
expensive evaluations and improved quality and efficiency of care. This pilot 
study is part of the larger Indianapolis Network for Patient Care (INPC) 
project whose goal is to link 12 of 14 EDs and hospitals in Indianapolis via L 
the RMRS to improve access to patients' clinical data. [31] 
From 1995-1996, data from the RMRS was made available to 
physicians in the ED at two different local hospitals. Upon patient registration 
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in the ED, an electronic copy of the face sheet was sent to the RMRS and the 
presence of a match in the database was determined. Patients identified as 
matches were randomized (by random number generator) to intervention or 
control, notification of eligibility for the study was sent back to the ED, and 
the patient was consented for entry into the trial. 
For intervention patients at either ED, physicians had access to RMRS 
data by two means. A printed clinical abstract generated from the most recent 
data in the RMRS was attached to the patient's chart in the ED for review. 
Direct online access for 24 hours was also available for physicians caring for 
intervention patients. For control patients, the computer generated an "empty" 
clinical abstract to signal that the patient's registration had been received. 
The primary outcome of interest was mean ED charge for a single 
encounter. In addition, researchers measured the ordering rates for several 
specific laboratory tests and assessed the frequency of hospital admission. 
Last, a physician survey questionnaire was administered to assess perceptions 
of the system. 
The authors demonstrated a statistically significant reduction in 
charges by $26 per encounter at one of the two hospitals. The other hospital 
showed no difference in mean charges. They observed no difference in 
ordering rates of laboratory tests, or hospital admission between intervention 
and control patients. The response rate for the survey was 50%. Seventy 
percent of respondents indicated that they would "like to receive a printed 
summary for all patients". Less than 0.5% of encounters at each study hospital 
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were associated with online access. Almost half of respondents cited 
forgetting their password and the time required to search for information as 
the top two barriers to use of the online system. 
That this well-conceived study of the effect of electronic access to 
clinical data did not yield notable differences between intervention and control 
patients is disappointing. A number of limitations in study processes may 
explain the absence of effect; they provide valuable examples of difficulties 
that need to be overcome in future studies. 
First. and most significant, is the context in which the study was 
performed. The authors note that the primary medical record at both hospitals 
is a traditional paper chart and that this was rarely retrieved in either location 
for ED care. Limited online resources for clinical data were available to 
physicians at the two hospitals and few physicians made use of them. Use of 
an electronic system for access to patient data in this setting would represent a 
striking change in work practice for these physicians. The short time frame 
for this project further limits physician familiarity and comfort with such a 
new and different system. 
Barriers to use of online access such as forgotten passwords and time 
required to locate desired data would be substantially reduced if the time 
period for the study were extended. Similarly, if the study occurred in a 
setting characterized by greater familiarity with use of electronic clinical data, 
results may have differed substantially. 
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In addition to contextual issues, the exact processes comprising the 
study protocol were not fully implemented, particularly at one of the two 
hospital sites. Printed abstracts were not available to physicians in 39% of 
cases at Methodist for a variety of reasons including difficulty using the 
printer and human error in attaching to the chart. 
The potential utility of shared electronic clinical data for patients 
receiving care across institutions is highlighted by data collected during the 
course of this study. Researchers report that more than 32,000 patients seen at 
the two study sites had data available in the RMRS system for more than 
50,000 encounters during the study year. Moreover, 6% of these patients 
visited more than one ED during that single year. 
Shared Care: GBS Prevention 
Implementation of GBS prevention guidelines in most settings requires 
shared care between an outpatient prenatal care site and an inpatient labor and 
delivery setting. Even if a single provider is involved across the two settings, 
access to the patient's clinical data is often compromised in the setting of a 
paper record system by time and labor intensive processes required to transfer 
paper records. The use of an electronic record with shared access across sites 
may improve the accuracy of GBS status awareness with subsequent 
improvement in the delivery of care according to the guideline. This effect 
has yet to be rigorously assessed in trials. 
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A report from a large West Coast HMO, in which an automated 
system is likely to link outpatient and inpatient components of care, could 
provide an example of an efficacy trial of guideline implementation. 
Unfortunately, the goals in this paper were to assess the rates of 
implementation and important data (GBS unknown/negative rate and numbers 
associated with lAP use in all GBS categories) are not provided. [17) 
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